Autocatalytic peptide bond cleavages in prothrombin and meizothrombin by Petrovan, Ramona J. et al.
 
 
 
Autocatalytic peptide bond cleavages in prothrombin
and meizothrombin
Citation for published version (APA):
Petrovan, R. J., Govers-Riemslag, J. W. P., Nowak, G., Hemker, H. C., Tans, G., & Rosing, J. (1998).
Autocatalytic peptide bond cleavages in prothrombin and meizothrombin. Biochemistry, 37(5), 1185-1191.
https://doi.org/10.1021/bi971948h
Document status and date:
Published: 03/02/1998
DOI:
10.1021/bi971948h
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Jan. 2021
Articles
Autocatalytic Peptide Bond Cleavages in Prothrombin and Meizothrombin†
Ramona J. Petrovan,‡,§ JoséW. P. Govers-Riemslag,‡ Götz Nowak,| H. Coenraad Hemker,‡ Guido Tans,‡ and
Jan Rosing*,‡
CardioVascular Research Institute Maastricht, Maastricht UniVersity, The Netherlands, and Max-Planck-Gesellschaft e.V.,
“Pharmacological Haemostaseology”, Friedrich Schiller UniVersity, Jena, Germany
ReceiVed August 6, 1997
ABSTRACT: During factor Xa-catalyzed prothrombin activation, several other reaction products accumulate
as a result of proteolysis of prothrombin and its activation products by thrombin and meizothrombin.
Gel electrophoretic analysis and N-terminal sequencing of reaction products showed that in the absence
of Ca2+ ions thrombin cleaved the following peptide bonds: Arg51-Thr52/Arg54-Asp55 in the fragment
1 (F1) domain (k ) 0.4 × 104 M-1 s-1), Arg155-Ser156 in prothrombin (k ) 2 × 104 M-1 s-1), and
Arg284-Thr285 in prethrombin 1 (k ) 0.02× 104 M-1 s-1). In the presence of 2.5 mM CaCl2, cleavage
in fragment 1 (Arg51-Thr52/Arg54-Asp55) was not detectable, whereas cleavage at Arg155-Ser156 (i.e.,
removal of F1) was inhibited 25-fold. Cleavage at Arg284-Thr285 (formation of prethrombin 2 des-1
13) was not affected by the presence of Ca2+ ions. Meizothrombin rapidly converted itself into
meizothrombin des-F1. The half-life (t1/2 ) ∼30 s) of this reaction was independent of the meizothrombin
concentration (0.1-1 µM meizothrombin), which is indicative for intramolecular autocatalysis (k ) 0.02
s-1 in the presence of 2.5 mM Ca2+ ions). Since the rapid removal of fragment 1 precludes investigations
of the cleavage at Arg284-Thr285 in intact meizothrombin, we analyzed the cleavage of this peptide bond
in R155A-meizothrombin, a recombinant product that is resistant to autocatalytic removal of the fragment
1 domain. In the absence of phospholipids, R155A-meizothrombin converted itself into thrombin des-
1-13 by a combination of intramolecular (k ) 0.8× 10-4 s-1) and intermolecular autocatalysis (k ) 0.2
× 103 M-1 s-1). Intramolecular autocatalytic conversion of R155A-meizothrombin into thrombin was
not affected by the presence of phospholipids (k ) 0.8× 10-4 s-1), whereas intermolecular autocatalysis
was accelerated 25-fold (k) 5.6× 103 M-1 s-1) by phospholipid vesicles. Since factor Xa/Va-catalyzed
conversion of meizothrombin into thrombin occurs withk ) 5.5 × 108 M-1 s-1, we conclude that in
reaction systems containing purified proteins autocatalysis of meizothrombin hardly contributes to thrombin
formation during factor Xa-catalyzed prothrombin activation.
The conversion of the zymogen prothrombin into its active
form thrombin is one of the central reactions of blood
coagulation. Thrombin formation is the result of cleavage
of two peptide bonds at Arg271 and Arg320 in prothrombin1
by blood coagulation factor Xa (Suttie & Jackson, 1977;
Heldebrant et al., 1973; Downing et al., 1975). Dependent
on the order of cleavage, two activation pathways are
possible and both intermediates, prethrombin 2 (Esmon et
al., 1974; Rosing et al., 1980) and meizothrombin (Krish-
naswamy et al., 1986; Rosing et al., 1986) are detected during
prothrombin activation. Prethrombin 2 has no catalytic
activity, while meizothrombin, a two-chain molecule with
the same molecular weight as prothrombin, exhibits full
esterolytic and amidolytic activity toward small substrates.
Compared with thrombin, meizothrombin has reduced activ-
ity on macromolecular thrombin substrates (Rhee et al., 1982;
Krishnaswamy et al.,1986; Doyle & Mann, 1990), which may
be enhanced, however, by the presence of negatively charged
phospholipids (Tans et al., 1994).
A clear description of product generation during prothrom-
bin activation is difficult because of very effective autocata-
lytic degradation of prothrombin and prothrombin activation
products. Thrombin and meizothrombin are capable of a
feedback reaction at Arg155-Ser156 bond in prothrombin or
meizothrombin. This results in the removal of fragment 1
(F1)2 and generation of prethrombin 1 or meizothrombin des-
† This work was supported by Program Grant 900-526-192 from the
Dutch Organisation for Scientific Research (NWO).
* To whom correspondence should be addressed: Department of
Biochemistry, Maastricht University, P.O. Box 616, 6200 MD Maas-
tricht, The Netherlands. Tel: 31-43-3881678. Fax: 31-43-3670988.
‡ Maastricht University.
§ On leave of absence from Max-Planck-Gesellschaft e.V., Unit for
“Pharmacological Haemostaseology” at the Friedrich Schiller Univer-
sity, Jena, Germany. Supported by Deutscher Akademischer Austaus-
chdienst and Deutsche Akademie der Naturforscher “Leopoldina”.
1 The numbering used corresponds to the cDNA sequence coding
for the human prothrombin (cf. Degen & Davie, 1987). Human
prothrombin consists of 579 residues whereas bovine prothrombin
contains 582 residues. Consequently, the numbering of amino acids of
human prothrombin differs by three residues from that of the bovine
molecule.
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F1 (Doyle & Mann, 1990; Esmon et al., 1974). Autopro-
teolysis at Arg284 in human prothrombin will give rise to a
form of thrombin (thrombin des-113), with a 13 amino
acid shorter A-chain, which has the same catalytic properties
as R-thrombin (Downing et al., 1975; Lanchantin et al.,
1973). When this cleavage occurs in meizothrombin, frag-
ment 1.2.3 and thrombin des-1- 3 are liberated (Doyle &
Mann, 1990 ; Rabiet et al., 1986). Other thrombin cleavage
sites within fragment 1 have been reported at Arg51 (Walz
et al., 1977) and at Arg54 (Board & Shaw, 1983). The latter
cleavage was recently reported as Arg55-Asp56 by Stevens
et al. (1996) in a recombinant stable meizothrombin with
the cleavage site mutations R155A, R271A, and R284A (in
the human cDNA numbering1 this is, however, Arg54-
Asp55). In thrombin, a number of additional bonds can be
cleaved by autocatalysis at the carboxyl-terminus of the
molecule (B-chain), resulting in forms of thrombin (â- and
γ-thrombin) with reduced procoagulant activity (Boissel et
al., 1984).
In plasma or whole blood only low amounts of fragment
1 (Rabiet et al., 1986; Aronson et al., 1977) or meizothrombin
(Tans et al., 1991) accumulate. This suggests the presence
of additional mechanisms which may protect prothrombin
from feedback proteolysis and alter the peptide bond cleavage
pattern during plasma prothrombin activation. To allow
evaluation of feedback reactions during prothrombin activa-
tion, we determined in a model system the rate constants of
autocatalytic cleavages in prothrombin and R155A-pro-
thrombin, a recombinant prothrombin in which Arg155 is
replaced by Ala and which, due to the amino acid substitu-
tion, cannot be converted into prethrombin 1 or meizothrom-
bin des-F1. This study was undertaken in order to elucidate
the possible physiological significance of feedback and/or
autocatalytic reactions duringin ViVo prothrombin activation.
EXPERIMENTAL PROCEDURES
Materials. Hepes, Tris, EDTA, bovine serum albumin,
and ovalbumin were purchased from Sigma Chemical Co.
DOPC and DOPS were obtained from Avanti Polar Lipids,
Pelham, AL. Small unilamellar phospholipid vesicles were
prepared as decribed before (Rosing et al., 1980). The
chromogenic substrate S2238 and the reversible thrombin
inhibitor I2581 were supplied by Chromogenix, Mo¨lndal,
Sweden. Ecarin, the prothrombin activator fromEchis
carinatusvenom, was purchased from Pentapharm, Swit-
zerland. Heparin (USP activity 175 units/mg) was purchased
from Organon. PPACK was obtained from Calbiochem, and
p-NPGB was from Nutritional Biochemicals. Micro BCA
protein assay kits were from Pierce, Rockford. Immobilon-P
membranes were obtained from Millipore, Bedford, MA.
Antibodies were supplied by Kordia, The Netherlands, and
Sigma Chemical Co. Rabbit antihuman F1.2 was a kind gift
of Dr. T. Lindhout, Maastricht University, The Netherlands.
Materials used for protein purification were purchased from
Pharmacia.
Proteins. The human coagulation factors used in this study
were purified from fresh frozen plasma. Human prothrombin
was purified according to DiScipio et al. (1977). Human
thrombin was prepared from prothrombin activation mixtures
by the method of Pletcher and Nelsestuen (1982). Recom-
binant prothrombin (R155A-prothrombin) was obtained and
purified as described before (Tans et al., 1994). Human
antithrombin III was isolated according to Thaler and Schmer
(1975). Prethrombin 1 and fragment 1 were purified from
a reaction mixture of human prothrombin with thrombin in
50 mM Tris (pH 7.9) and 175 mM NaCl. After inhibition
of thrombin with PPACK, the reaction mixture was applied
to a column (XK 5/10) with Q Sepharose fast flow.
Prethrombin 1 did not adhere to the resin, and fragment 1
and noncleaved prothrombin were eluted with a gradient of
250 to 600 mM NaCl. Fragment 1 was separated from
prothrombin by gel permeation chromatography on a Su-
perdex 200 HiLoad (16/60) column in 25 mM Hepes (pH
7.7) and 175 mM NaCl. R155A-meizothrombin, meizo-
thrombin, and meizothrombin des-fragment 1 were obtained
from reaction mixtures in which R155A-prothrombin or
prothrombin were incubated with purified prothrombin
activators fromEchis carinatusor Echis coloratus(Tans et
al., 1994). Prothrombin, R155A-prothrombin, antithrombin
III, prethrombin 1, fragment 1, and thrombin were stored at
-80°C. Protein preparations were homogeneous and>95%
pure as judged by SDS-PAGE according to Laemmli
(1970).
Protein Concentrations. Protein concentrations were
determined with the micro BCA protein assay (Smith et al.,
1985). Molar thrombin concentrations were determined by
active site titration withp-NPGB (Chase & Shaw, 1969).
Prothrombin concentrations were determined after complete
activation of prothrombin withEchis carinatusvenom and
quantitation of thrombin withp-NPGB. Meizothrombin and
R155A-meizothrombin concentrations were determined with
S2238, considering that the amidolytic activity per mole is
the same as that of thrombin (Rosing et al., 1986; Doyle &
Mann, 1990).
Measurement of Prothrombin ActiVation. Amidolytic
activity (thrombin, meizothrombin, and/or meizothrombin
des-F1) generated during prothrombin activation was deter-
mined by transferring samples from reaction mixtures to
cuvettes containing a final volume of 1 mL of 50 mM Tris-
HCl (pH 7.9), 175 mM NaCl, 20 mM EDTA, 0.5 mg/mL
ovalbumin, and 235µM S2238 at 37°C, as described earlier
(Rosing et al., 1986). Quantitation of meizothrombin plus
meizothrombin des-F1 was performed in appropriate dilu-
tions by measurement of the activity toward S2238, that
remained after 1 min incubation with 5 nM AT III in the
presence of 30µg/mL heparin, as described before (Rosing
et al., 1986). This assay does not discriminate between
meizothrombin and meizothrombin des-F1, since under the
assay conditions they exhibit the same activity toward S2238
and are equally inhibited by AT-III plus heparin.
Gel Electrophoretic and Immunoblot Analysis. Products
of prothrombin proteolysis were analyzed after SDS-PAGE
on 13% slabgels according to Laemmli (1970) and identified
after staining with Coomassie Brilliant Blue R-250 or after
electrophoretic transfer of proteins from the gel to Immo-
2 Abbreviations: AT-III, antithrombin III; BCA, bicinchoninic acid;
BSA, bovine serum albumin; DOPC, 1,2-dioleoyl-sn-glycero-3-phos-
phocholine; DOPS, 1,2-dioleoyl-sn-glycero-3-phosphoserine; F1, frag-
ment 1; F1.2, fragment 1.2;p-NPGB,p-nitrophenylp′-guanidinoben-
zoate hydrochloride; SDS, sodium dodecyl sulfate; SDS-PAGE,
polyacrylamide gel electrophoresis in the presence of SDS; S2238,
D-Phe-(pipecolyl)-Arg-pNA; prethrombin 2 des-1- 3, prethrombin 2
lacking Thr272-Arg284; thrombin des-1-13, thrombin lacking Thr272-
Arg284; PPACK, phenylalanyl-prolyl-arginine chloromethyl ketone.
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bilon-P membranes and visualization with a polyclonal
rabbit-antibody directed against the human F1.2 and goat
anti-rabbit IgG conjugated with alkaline phosphatase as
described by Blake et al. (1984). The immunoblots were
scanned on a Pharmacia Image Master DTS scanner and the
amounts of proteins were quantified using the “Image Master
1D” program as percentage of staining intensity of the same
protein bands in the sample taken at time zero. The relation
between the staining intensity and the amount of protein on
the gel was determined on separate gels that contained
varying known amounts of prothrombin, prethrombin 1, or
fragment 1 per lane.
Amino-Terminal Sequence Analysis. Prothrombin (5µM)
was incubated at 37°C for 2 h with 2µM thrombin in the
absence of Ca2+ in 25 mM Hepes (pH 7.7) and 175 mM
NaCl. The reaction products were separated by SDS-PAGE
on 13% reduced gels, transfered to Immobilon-P membranes
in 50 mM Tris-borate (pH 8.4) and 20% methanol, and
stained with diluted Coomassie Brilliant Blue R-250. Protein
bands were cut from the blots and subjected to automated
amino-terminal sequencing on a Procise 494 Sequencer from
Applied Biosystems, Foster City, CA (Protein Laboratory,
IMB-Jena Germany).
Kinetic Analysis of Time Courses of Proteolysis. Time
courses of prothrombin, prethrombin1, meizothrombin, or
fragment 1 proteolysis were followed by SDS-PAGE,
immunoblotting, and quantitation of the intensity of the
protein bands on the blots as described above. The fraction
of substrate remaining at each time interval (St/S0) was plotted
vs time and the pseudo-first-order rate constants (k) were
obtained by fitting the time courses of prothrombin, pre-
thrombin 1, meizothrombin, or fragment 1 disappearance to
a single exponential (St ) S0e-kt, in whichS0 ) the intensity
of the protein band atT ) 0 andSt ) the intensity of the
protein band atT) t) using nonlinear least squares regression
analysis. Second-order rate constants were obtained by
dividing the pseudo-first-order rate constant by the enzyme
concentration.
RESULTS
Peptide Bonds in Human Prothrombin Susceptible to
Feedback Proteolysis by Thrombin. The time course of
product generation during feedback reactions of thrombin
on prothrombin was followed by SDS-PAGE and visualiza-
tion of protein bands by staining with Coomassie Blue
(Figure 1). In the absence of Ca2+ ions, considerable
amounts of prethrombin 1 and fragment 1 were formed in
the early phase of the incubation. Their concentration
decreased after prolonged incubation with formation of
products with lower molecular weights (designated band 1,
2, and 3, cf. Figure 1). The appearance of these bands is
indicative for thrombin-catalyzed cleavages in prethrombin
1 and fragment 1.
Amino-terminal sequence analysis of the protein bands 1,
2, and 3 formed during incubation of prothrombin with
thrombin in the absence of Ca2+ yielded the following
sequences: band 1, Thr-Phe-Gly-Ser-Gly-Glu-Ala-Asp, band
2, Ser-Glu-Gly-Ser-Ser-Val-Asn-Leu, and band 3, Thr-Pro-
Arg-Asp-Lys-Leu-Ala-Ala and Asp-Lys-Leu-Ala-Ala-?-Leu-
Glu. Comparison with the primary amino acid sequence of
human prothrombin (Degen & Davie, 1987) indicates that
these products result from thrombin-catalyzed cleavages at
Arg284-Thr285 in prethrombin 1 giving rise to prethrombin
2 des-1-13 (band 1) and fragment 2.3 (band 2) and at
Arg51-Thr52 and Arg54-Asp55 in the fragment 1 region
resulting in the formation of fragments with apparentMr ≈
20 kDa (band 3) and 7 kDa (not visible on the gel) derived
from fragment 1.
Effect of Ca2+ Ions on Proteolysis of Human Prothrombin,
Prethrombin 1, and Fragment 1 by Thrombin. Earlier
investigations on the removal of fragment 1 from bovine
prothrombin by thrombin and on the cleavage at Arg54-
Asp55 in recombinant meizothrombin demonstrated inhibition
by Ca2+ (Silverberg, 1979; Stevens et al., 1996). To evaluate
the effect of Ca2+ ions on the thrombin-catalyzed cleavages
at Arg155-Ser156, Arg284-Thr285, and Arg51-Thr52/Arg54-
Asp55, the disappearance of the substrates for these peptide
FIGURE 1: Gel electrophoretic analysis of proteolysis of prothrombin by thrombin. Prothrombin (3µM) was incubated with 0.75µM
thrombin in a reaction mixture containing 25 mM Hepes (pH 7.7) and 175 mM NaCl at 37°C. At the indicated times, aliquots of the
reaction mixture were reduced with 5%â-mercaptoethanol and subjected to SDS-PAGE on 13% gels. The gels were stained with Coomassie
Brilliant Blue R-250. The left lane contains a reference mixture of prothrombin (PT), prethrombin 1 (PT 1), thrombin (T), and fragment 1
(F1). Further details are given in the Experimental procedures.
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bond cleavages (prothrombin, prethrombin 1 and fragment
1) was followed by SDS-PAGE analysis, immunoblotting,
and staining of the protein bands with appropriate antibodies.
From calibration curves obtained in a separate experiment,
a linear relationship was established between the staining
intensity of prothrombin, prethrombin 1, or fragment 1 and
the amount of protein on the blot (data not shown), and
therefore, quantification of the protein bands via scanning
of immunoblots of time courses was used to determine the
rate of peptide bond cleavages in prothrombin, prethrombin
1 and fragment 1.
Figure 2A shows the time courses of thrombin-catalyzed
cleavages in prothrombin, prethrombin 1, and fragment 1 in
the absence of Ca2+ ions. The time courses could be fitted
with a single exponential equation and yielded pseudo-first-
order rate constants for thrombin-catalyzed cleavages at
Arg51-Thr52/Arg54-Asp55, Arg155-Ser156, and Arg284-Thr285.
Variation of the concentrations of reactants showed that the
rates of peptide bond cleavages were first-order in both
substrate (0-2 µM prothrombin, prethrombin 1, or fragment
1) and enzyme (0-2 µM thrombin). This allows calculation
of second-order rate constants (Table 1) from the pseudo-
first-order rate constants obtained from the exponential fits.
In the presence of Ca2+ ions (Figure 2B), proteolysis in
fragment 1 was completely inhibited and proteolysis of
human prothrombin to prethrombin 1 and fragment 1 was
slowed down about 25-fold, whereas no significant changes
of the rate of cleavage at Arg284-Thr285 in prethrombin 1
were observed (Table 1).
Autocatalytic ConVersion of Meizothrombin. The obser-
vation that thrombin can cleave the Arg284-Thr285 bond in
prothrombin/prethrombin 1 encouraged us to test whether
meizothrombin can also cleave this peptide bond in itself
and thus contribute to thrombin formation (thrombin des-
1-13) via autocatalysis. Meizothrombin is a reaction
intermediate that is formed in the early phase of factor Xa-
catalyzed prothrombin activation and that is subsequently
converted into thrombin (Rosing et al., 1986; Krishnaswamy
et al., 1986). However, human meizothrombin is rapidly
converted into meizothrombin des-F1 by autocatalytic feed-
back cleavage (Doyle & Mann, 1990). Since meizothrombin
des-F1 lacks the gla-containing phospholipid-binding domain
this reaction precludes studies of the autocatalytic cleavage
at Arg284-Thr285 in intact meizothrombin, especially in the
presence of phospholipids.
Therefore, we first determined the rate constant for
conversion of meizothrombin into meizothrombin des-F1
(Figure 3). Time courses of meizothrombin disappearance
in the absence and presence of phospholipids were fitted to
a single exponentional equation and it appeared that phos-
pholipids did not influence the rate of conversion of
meizothrombin into meizothrombin des-F1 (Figure 3, Table
2). Since the half-life of meizothrombin was independent
of the concentration (0.1-1 µM meizothrombin, data not
shown), we conclude that the removal of fragment 1 from
meizothrombin is a first-order reaction in which each
meizothrombin molecule cleaves off its own fragment 1
Table 1: Rate Constants of Proteolytic Cleavages in Human Prothrombina
k (M-1 s-1)
substrate enzyme peptide bond products no Ca2+ 2.5 mM Ca2+
PT thrombin Arg155-Ser156 PT1, F1 2× 104 0.08× 104
PT1 thrombin Arg284-Thr285 PT2 des-1-13, F2.3 0.02× 104 0.02× 104
F1 thrombin Arg51-Thr52 7 kDa, 20 kDa fragments 0.4× 104 <10
Arg54-Asp55
aRate constants of thrombin-catalyzed cleavage of human prothrombin, prethrombin 1, and fragment 1 were obtained by fitting the time courses
presented in Figure 2 to a single exponential equation. Further experimental details are given in the Experimental Procedures. PT) prothrombin,
PT1) prethrombin 1, F1) fragment 1.
FIGURE 2: Time courses of prothrombin, prethrombin 1, and
fragment 1 proteolysis by thrombin. Proteolysis of 0.5µM
prothrombin (9), prethrombin 1 (b), or fragment 1 (2) was
followed at 37°C in reaction mixtures containing 25 mM Hepes
(pH 7.7), 175 mM NaCl, and 0.4µM thrombin without CaCl2 (panel
A) or 0.8 µM thrombin in the presence of 2.5 mM CaCl2 (panel
B). After various time intervals aliquots from the reaction mixture
were diluted in SDS-electrophoresis buffer (with 5%â-mercap-
toethanol) and 10µL of these samples was subjected to SDS-
PAGE on 13% slab gels, immunoblotting and quantification of the
staining intensity of protein bands as described in the Experimental
Procedures. The solid lines represent exponential curves obtained
by fitting the data to the equation given in the Experimental
Procedures.
FIGURE 3: Time courses of autocatalytic removal of fragment 1
from meizothrombin. Meizothrombin (0.5µM) was incubated at
37 °C in reaction mixtures containing 25 mM Hepes (pH 7.7), 175
mM NaCl, 2.5 mM CaCl2, and no phospholipid (O) or 25 µM
DOPS/DOPC (25/75, mol/mol) vesicles (b). After various time
intervals aliquots from the reaction mixture were diluted in SDS-
electrophoresis buffer (with 5%â-mercaptoethanol) and 10µL of
these samples was subjected to SDS-PAGE on 13% slab gels,
immunoblotting, and quantification of the staining intensity of the
meizothrombin band as described in the Experimental Procedures.
The solid lines represent exponential curves obtained by fitting the
data to the equation given in the Experimental Procedures.
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domain via intramolecular autocatalysis [see Sanny et al.
(1975) for intramolecular autoactivation of pepsinogen]. A
similar mechanism of autocatalysis was recently also reported
for the cleavage at Arg54-Asp55 (Stevens et al., 1996).
The rates of peptide bond cleavage at Arg284 were
determined in meizothrombin des-F1 and in R155A-meizo-
thrombin, derived from a recombinant prothrombin that is
resistant to removal of fragment 1 (Tans et al., 1994). Figure
4A shows time courses of autocatalytic conversion of 0.25
µM meizothrombin des-F1 or R155A-meizothrombin into
thrombin in the absence and presence of phospholipids. In
the absence of negatively charged phospholipid vesicles,
meizothrombin des-F1 and R155A-meizothrombin were
converted into thrombin at similar rates. The presence of
phospholipids hardly affected autocatalytic conversion of
meizothrombin des-F1 into thrombin. In contrast, in the case
of R155A-meizothrombin, the presence of 25µM phospho-
lipids considerably stimulated autocatalytic thrombin forma-
tion (Figure 4A). The phospholipid stimulation of autocat-
alytic conversion of R155A-meizothrombin into thrombin
appeared to be dependent on the phospholipid concentration,
and optimal rates of autocatalytic thrombin formation were
observed at∼20 µM phospholipid (Figure 4B). At all
meizothrombin des-F1 and R155A-meizothrombin concen-
trations tested, autocatalytic thrombin formation could be
described by a single exponential. Figure 5 shows the
pseudo-first-order rate constants (kobs) obtained from time
courses of autocatalytic thrombin formation determined at
varying meizothrombin des-F1 and R155A-meizothrombin
concentrations. It appeared thatkobswas neither independent
of the meizothrombin concentration (intramolecular autoca-
talysis, a first-order reaction withkobs) constant) nor linearly
dependent on the meizothrombin concentration (intermo-
lecular autocatalysis, a second-order reaction withkobs) k2-
[MT]). This indicates that autocatalytic conversion of
meizothrombin des-F1 or R155A-meizothrombin into throm-
bin is the result of mixed intramolecular and intermolecular
autocatalysis. In that case, a plot ofkobsversus meizothrom-
bin concentration should yield a straight linekobs ) k1 +
k2[MT], in which k1 is the first-order rate constant for
intramolecular autocatalysis andk2 is the second-order rate
constant for intermolecular autocatalysis. The occurrence
of both intra- and intermolecular autocatalysis and the
validity of this equation is demonstrated in the insert of
Figure 5 which shows an enlargement of thekobs of
autocatalytic thrombin formation at low meizothrombin des-
F1 concentrations.
It can be argued that the intramolecular component of
autocatalytic conversion of meizothrombin into thrombin is
Table 2: Rate Constants of Peptide Bond Cleavages in Meizothrombina
no PL + 25µM PL
substrate enzyme cleavage site product k1 (s-1) k2 (M-1 s-1) k1 (s-1) k2 (M-1 s-1)
MT MT Arg155-Ser156 MT des-F1, F1 207× 10-4 245× 10-4
MT des-F1 MT des-F1 Arg284-Thr285 T des-1-13, F2.3 0.7× 10-4 0.4× 103 0.8× 10-4 0.3× 103
R155A-MT R155A-MT Arg284-Thr285 T des-1-13, F1.2.3 0.8× 10-4 0.2× 103 0.8× 10-4 5.6× 103
R155A-MT FXa/Va Arg271-Thr272 T, F1.2 nd 5.5× 108
aRate constants of intramolecular (k1) and intermolecular (k2) autocatalytic cleavage in meizothrombin and R155A-meizothrombin were obtained
from plots ofkobs as function of the meizothrombin concentration (Figure 5). Second-order rate constants of factor Xa/Va-catalyzed conversion of
R155A-meizothrombin into thrombin were obtained from initial rates of thrombin formation. MT) meizothrombin, T) thrombin, F1) fragment
1, F1.2) fragment 1.2, F1.2.3) fragment 1.2.3, F2.3) fragment 2.3, nd) not determined.
FIGURE 4: Effect of phospholipid on the autocatalytic conversion
of meizothrombin des-F1 and R155A-meizothrombin into thrombin
des-1-13. (A) Meizothrombin (0.25µM) des-F1 (0, 9) or R155A-
meizothrombin (4,2) were incubated at 37°C in a reaction mixture
containing 25 mM Hepes (pH 7.7), 175 mM NaCl, 0.5 mg/mL
ovalbumin, 2.5 mM CaCl2, and no phospholipids (0, 4) or 25µM
DOPS/DOPC (25/75, mol/mol) vesicles (9,2). At the time intervals
indicated, aliquots were withdrawn for analysis of thrombin
formation as described in the Experimental Procedures. The solid
lines represent exponential curves obtained by fitting the data to
the equation given in the Experimental Procedures. (B) Pseudo-
first-order rate constants (kobs) obtained from exponential fits of
time courses of 0.25µM R155A-meizothrombin dissappearance at
varying amounts of DOPS/DOPC (25/75, mol/mol) vesicles.
FIGURE 5: Autocatalytic conversion of meizothrombin des-F1 and
R155A-meizothrombin into thrombin des-1- 3 at varying con-
centrations. Varying amounts of meizothrombin des-F1 (0, 9) or
R155A-meizothrombin (4,2) were incubated at 37°C in a reaction
mixture containing 25 mM Hepes (pH 7.7), 175 mM NaCl, 0.5
mg/mL ovalbumin, 2.5 mM CaCl2, and no phospholipids (0, 4)
or 25µM DOPS/DOPC (25/75, mol/mol) vesicles (9, 2). Pseudo-
first-order rate constants (kobs) were obtained from exponential fits
of time courses of meizothrombin des-F1 and R155A-meizothrom-
bin dissappearance as in Figure 4. Plotted iskobs as a function of
the meizothrombin des-F1 or R155A-meizothrombin concentration.
The inset shows an enlargement ofkobs for meizothrombin des-F1
illustrating the validity of the equationkobs) k1 + k2[MT] to obtain
the intramolecular (k1 ) intercept at [MT]) 0) and intermolecular
(k2 ) slope of the line) component of autocatalysis. The solid lines
represent the best fit of the data to the equation and thek1 andk2
values obtained are summarized in Table 2.
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not due to meizothrombin itself but is caused by a contami-
nating proteolytic enzyme present in the reaction mixture,
e.g., in the ecarin used for preparation of meizothrombin or
in ovalbumin, the carrier protein routinely used in our
reaction mixtures. Since addition of excess ecarin or
ovalbumin did not affect the time courses of autocatalytic
thrombin formation, we exclude this possibility and we
conclude that this results of a mixed intramolecular and
intermolecular autocatalysis with rate constantsk1 and k2,
respectively. The values fork1 andk2 calculated from Figure
5 and summarized in Table 2 show that the rate constants
for intramolecular autocatalysis (k1, intersection at [MT])
0) hardly differed for meizothrombin des-F1 or R155A-
meizothrombin and were not affected by the presence of
phospholipids. In addition, the rate constants for intermo-
lecular autocatalysis (k2, slope of the line) are similar for
meizothrombin des-F1 (with and without phospholipids) and
R155A-meizothrombin (without phospholipids). Phospho-
lipids only affected intermolecular autocatalysis of R155A-
meizothrombin the rate constant of which was enhanced
some 25-fold (Table 2).
DISCUSSION
Conversion of prothrombin into thrombin by factor Xa is
accompanied by generation of several intermediates and
products due to feedback reactions catalyzed by thrombin
and meizothrombin. The data presented in this paper provide
insight in the potential significance of autocatalytic reactions
during the activation of human prothrombin.
In agreement with earlier studies (Walz et al., 1977; Board
& Shaw, 1983; Stevens et al., 1996), thrombin cleavages in
human prothrombin were identified at Arg51-Thr52/Arg54-
Asp55, Arg155-Ser156, and Arg284-Thr285. The rate of
cleavage at these peptide bonds is greatly affected by the
reaction conditions. In the absence of Ca2+ ions, thrombin
relatively efficiently proteolyzes peptide bonds within the
fragment 1.2 region (Arg51-Thr52/Arg54-Asp55 and Arg155-
Ser156). The presence of calcium ions inhibits the removal
of fragment 1 some 25-fold and prevents cleavage at Arg51-
Thr52/Arg54-Asp55 in fragment 1. Stevens et al. (1996)
observed a similar inhibition for cleavage at Arg54-Asp55
which is presumably due to sequestering of the peptide bond
inside the fragment 1 region upon the binding of calcium to
the gla-domain (Stevens et al, 1996). This conformational
change, possibly in combination with a reduction of the
negative charge of the gla-domain after binding Ca2+ ions,
may also be responsible for the 25-fold inhibition of the rate
of cleavage at Arg155 (Silverberg, 1979; Bjork & Stenflo,
1973; Nelsestuen & Lim, 1977). The fact that prothrombin
is significantly protected from proteolysis by the presence
of Ca2+ likely explains why low amounts of fragment 1 are
detectable during prothrombin activation in plasma (Boissel
et al., 1985; Silverberg, 1979).
It has been reported that during prothrombin activation in
plasma fragment 1.2.3 is formed (Rabiet et al., 1986), and it
was hypothesized that this may be indicative for a contribu-
tion of thrombin/meizothrombin to thrombin formation by
cleavage at Arg284-Thr285. However, comparison of the rates
of peptide bond cleavage at Arg271-Thr272 by factor Xa-Va
[k) 5.5× 108 M-1 s-1, cf. Mann et al. (1990) and Table 2]
and cleavage at Arg284-Thr285 by thrombin (k ) 0.2× 103
M-1 s-1) shows that on a kinetic basis thrombin itself will
hardly contribute to its own formation when factor Xa is
present.
It is possible, however, that meizothrombin can autocata-
lytically cleave the Arg284-Thr285 at a faster rate. Meizo-
thrombin has an exposed active site and contains a gla-
domain that enables its binding to phospholipids which may
result in enhancement of its catalytic activity (Tans et al.,
1990). Studies on autocatalytic cleavages in and by intact
meizothrombin are, however, hampered by the fact that the
gla-containing fragment 1 domain is readily cleaved off by
autocatalysis (Doyle & Mann, 1990). In this paper, we show
that the Arg155-Ser156 bond in meizothrombin is indeed
cleaved at a high rate. In the presence of Ca2+ ions, the
rate of cleavage in 1µM meizothrombin is approximately
25-times higher than thrombin-catalyzed cleavage of the
same bond in prothrombin. In contrast to the latter reaction
the autocatalytic removal of the fragment 1 domain from
meizothrombin yields a constant half-life at all meizothrom-
bin concentrations (t1/2 ) ∼30 s), which is indicative of a
first-order reaction in which each meizothrombin molecule
proteolyses itself via intramolecular autocatalysis [cf. Sanny
et al. (1975) for intramolecular activation of pepsinogen].
Stevens et al. (1996) also reported an intramolecular mech-
anism of autocatalysis for cleavage at Arg54. Considering
the high rate of intramolecular autocatalysis, meizothrombin
is apparently folded in such a way that the fragment 1 region
is readily available for entry into the active site and cleavage
at Arg155.
The rapid removal of fragment 1 from meizothrombin
precludes studies on autocatalytic cleavage of the Arg284-
Thr285 bond in intact meizothrombin. This cleavage was,
therefore, quantitated in meizothrombin des-F1 and in a
recombinant derivative (R155A-meizothrombin) that is re-
sistant to removal of fragment 1. In the absence of
phospholipids, the Arg284-Thr285 bond was cleaved in
meizothrombin des-F1 and R155A-meizothrombin at similar
rates. Phospholipids did not affect autocatalytic thrombin
formation with meizothrombin des-F1 as substrate and
considerably enhanced this reaction in the case of R155A-
meizothrombin (Figure 4).
The dependency of the observed rate constant as a function
of the meizothrombin concentration (Figure 5) indicates that
cleavage of the Arg284-Thr285 bond results from a combina-
tion of an intramolecular first-order reaction (rate constant
independent of meizothrombin concentration) and an inter-
molecular second-order reaction (pseudo-first-order rate
constant linearly dependent on the meizothrombin concentra-
tion). The rate constant for intramolecular autocatalysis
appeared to be similar for both forms of meizothrombin [k1
) (0.8-0.9) × 10-4 s-1] and was not affected by the
presence of phospholipids (Table 2).
The fact that intramolecular autocatalytic cleavage of
Arg284-Thr285 contributes to the conversion of meizothrom-
bin into thrombin conversion (cf. Figure 5 and Table 2) came
somewhat as a surprise. Recently, van de Locht et al. (1996)
reported that residues 284-320, which form the truncated
A-chain of R-thrombin, are located to the back of the
molecule, away from the active site. On the basis of this
and on crystallographic data available for the complex of
fragment 2 with thrombin (Arni et al., 1993), they proposed
a hypothetical conformation which would position residues
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271-284 also at the back of the active site in meizothrombin
(van de Locht et al., 1996). The very slow rate constant for
intramolecular autocatalysis indicates that entry of Arg284 in
the active site is indeed an unlikely event. However, our
data suggest that it is not impossible and that meizothrombin
is apparently sufficiently flexible to allow for cleavage at
Arg284. Phospholipids only stimulated intermolecular auto-
catalysis of R155A-meizothrombin (25-fold increase ofk2).
This is not surprising since intermolecular autocatalysis is a
bimolecular reaction which, due to coordinated binding of
substrate and enzyme and enhanced enzyme-substrate com-
plex formation, will proceed at higher rates at the phospho-
lipid surface [cf. Mann et al. (1990)].
A comparison of the rate constant for meizothrombin
autocatalysis at Arg284 (k2 ) 5.6× 103 M-1 s-1) and factor
Xa/Va-catalyzed cleavage at Arg271 (k) 5.5× 108 M-1 s-1)
indicates that on a theoretical basis autoproteolysis in
meizothrombin can hardly contribute to thrombin formation
and will have 50% contribution after the factor Xa/Va
complex has catalyzed 105 turnovers, i.e., when the concen-
tration of meizothrombin is 105 times higher than that of
the factor Xa/Va complex. Moreover, meizothrombin-
catalyzed cleavage at Arg284 was not stimulated by factor
Va [alone or in combination with phospholipid vesicles (data
not shown)]. Our observation that the fragment 1 domain
is rapidly removed from meizothrombin (t1/2)∼30 s) further
reduces the contribution of meizothrombin to thrombin
formation since the rate of Arg284-Thr285 cleavage in
meizothrombin des-F1 is even 15 times slower than that in
intact meizothrombin (Table 2).
The data obtained in model systems cannot explain the
formation of fragment 1.2.3 during prothrombin activation
in plasma (Rabiet et al., 1986), which indicates that cleavage
at Arg284-Thr285 contributes to plasma thrombin formation.
It is possible that as yet unknown plasma factors may
influence the actual rate of peptide bond cleavages in
prothrombin. However, further conclusions regarding the
contribution of cleavage at Arg284-Thr285 to thrombin
formation have to await kinetic analysis of plasma prothrom-
bin activation.
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